Yes there have been some changes to the messaging around the commencement of the next trial, was to start 1st half ( perhaps that was just the ethics approval) now MT is gone it’s “The pivotal and adaptive Phase 2/3 study is expected to commence later in CY2024”. Hope the 2 event are related in any way. Looking fwd to further updates and clarity, that might come once funding is sorted if required post ODD.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1282
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.5¢ | $125.5K | 754.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 162762 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 91996 | 3 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |